Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gain Therapeutics (GANX) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Gain Therapeutics (GANX) over the last 6 years, with Q3 2025 value amounting to $891648.0.

  • Gain Therapeutics' Total Non-Current Liabilities rose 350.1% to $891648.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $891648.0, marking a year-over-year increase of 350.1%. This contributed to the annual value of $872989.0 for FY2024, which is 1925.35% down from last year.
  • As of Q3 2025, Gain Therapeutics' Total Non-Current Liabilities stood at $891648.0, which was up 350.1% from $940886.0 recorded in Q2 2025.
  • In the past 5 years, Gain Therapeutics' Total Non-Current Liabilities ranged from a high of $1.6 million in Q4 2021 and a low of $815921.0 during Q1 2025
  • Over the past 5 years, Gain Therapeutics' median Total Non-Current Liabilities value was $1.1 million (recorded in 2023), while the average stood at $1.2 million.
  • Per our database at Business Quant, Gain Therapeutics' Total Non-Current Liabilities soared by 2543.16% in 2021 and then tumbled by 4376.36% in 2024.
  • Over the past 5 years, Gain Therapeutics' Total Non-Current Liabilities (Quarter) stood at $1.6 million in 2021, then crashed by 32.22% to $1.1 million in 2022, then decreased by 1.23% to $1.1 million in 2023, then fell by 19.25% to $872989.0 in 2024, then rose by 2.14% to $891648.0 in 2025.
  • Its Total Non-Current Liabilities stands at $891648.0 for Q3 2025, versus $940886.0 for Q2 2025 and $815921.0 for Q1 2025.